IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Agex Therapeutics Inc (AGEGBP)

CUSIP: 00848H108 | X1 | 124 institutional holders

Quarters

Q2 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AJuvenescence Limited4,400,78127.3%New 5%+ stakeMar 20, 2026No 13F filer matched
13D/AJuvenescence Limited4,400,781
27.3% of class · Mar 20, 2026New 5%+ stake
No 13F filer matched

Institutional Holders — Q2 2024

Strategic Investment Solutions, Inc.250
0.0% of portfolio›$405
StyleTurnoverLocationFiled
Strategic Investment Solutions, Inc.
250$4050.0%ETFMediumOrland Park, IL2024-08-30